INS and metabolic dysfunction-associated steatotic liver disease: Consistent with our findings, administration of SFN (0.56 g/kg) for 6 weeks significantly improved glucose tolerance and insulin sensitivity in male mice with non-alcoholic fatty liver disease [37].